Year

Vaccine Licensure

Legislation and/or Policy Statements

IOM Reports on Vaccine Safety

1994

 

 

Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality

DPT and Chronic Nervous System Dysfunction: A New Analysis

1995

Varicella virus vaccine available (Varivax)

 

 

1996

DTaP vaccine licensed for first three doses given in infancy (Tripedia and ACEL-IMUNE were previously licensed for only the 4th and 5th doses).

ACIP recommends using IPV for the first 2 polio vaccinations, followed by OPV for remaining doses. Intended to be a transitional schedule for 3–5 years until an all-IPV series is available

ACIP recommends children 12 months to 12 years receive Varicella vaccine

Options for Poliomyelitis Vaccinations in the United States: Workshop Summary

1997

Additional DTaP vaccine (Infanrix) licensed for first 4 doses of 5-part series

ACIP recommends DTaP in place of DTP

Vaccine Safety Forum: Summary of Two Workshops

Risk Communication and Vaccination: Workshop Summary

1998

Additional DTaP vaccine (Certiva) licensed for first 4 doses of 5-part series

ACIP updates MMR recommendation, encouraging use of the combined MMR vaccine

 



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement